Recombinant EGFR (Nimotuzumab Biosimilar) anticorps
Reactivité: Humain
BR, FACS, IHC
Hôte: Human
Monoclonal
H-R3
unconjugated
Recombinant Antibody
-
- Antigène Tous les produits EGFR (Nimotuzumab Biosimilar)
- EGFR (Nimotuzumab Biosimilar)
- Type d'anticorp
- Recombinant Antibody
- Reactivité
- Humain
-
Hôte
-
Human
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp EGFR (Nimotuzumab Biosimilar) est non-conjugé
- Application
- Blocking Reagent (BR), Flow Cytometry (FACS), Immunohistochemistry (IHC)
- Attributs du produit
-
Original Species of Ab: Human
Original Format of Ab: IgG1
- Purification
- Purified antibody.
- Immunogène
- This antibody we generated by humanisation of the murine antibody R3, raised against EGFR purified from placenta membranes and A431 tumors.
- Clone
- H-R3
- Isotype
- IgG1 kappa
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Buffer
- PBS with 0.02 % Proclin 300.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
- Antigène
- EGFR (Nimotuzumab Biosimilar)
- Abstract
- EGFR (Nimotuzumab Biosimilar) Produits
- Synonymes
- anticorps ERBB, anticorps ERBB1, anticorps HER1, anticorps PIG61, anticorps mENA, anticorps epidermal growth factor receptor, anticorps EGFR
- Classe de substances
- Biosimilar
- Sujet
- ERBB-D3, ERBB1, HER1, PIG61, mENA, avian erythroblastic leukemia viral (v-erb-b) oncogene homolog, cell growth inhibiting protein 40, cell proliferation-inducing protein 61, proto-oncogene c-ErbB-1, receptor tyrosine-protein kinase erbB-1, epidermal growth factor
- UniProt
- P00533
-
Vous êtes ici:
